Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,122.00p
   
  • Change Today:
    -3.00p
  • 52 Week High: 1,195.50
  • 52 Week Low: 896.20
  • Currency: UK Pounds
  • Shares Issued: 874.35m
  • Volume: 3,601,344
  • Market Cap: £9,810m
  • RiskGrade: 173

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (26-07-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 2.6% 0.0%
Div Cover 2.2 2.5
Op Mrgn 7.7% 16.1%
ROCE 9.1%  
Latest F'cast
P/E 17.5 15.2
PEG 14.3 n/a
Pr/Revenue 2.3 1.6
Pr/Book 2.4  
Latest F'cast
Revenue 6.4% -18.6%
PBT 23.4% 150.9%
EPS 1.2% -13.1%
DPS n/a -39.9%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 23.1 23.1 +1% 37.50¢ 1.6%
31-Dec-20 4,560.00 246.00 64.60¢ 30.1 n/a -37% 37.50¢ 1.9%
31-Dec-21 5,212.00 586.00 80.90¢ 20.6 0.8 +25% 37.50¢ 2.3%
31-Dec-22 5,215.00 235.00 81.80¢ 17.5 17.5 +1% 37.50¢ 2.6%
31-Dec-23 5,549.00 290.00 82.80¢ 16.8 16.8 +1% 37.50¢ 2.7%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,809.64 936.11 71.93p 15.6 n/a -13% 29.02p 0.0%
31-Dec-25 6,119.48 1,094.81 85.34p 13.2 0.7 +19% 32.53p 0.0%
31-Dec-26 6,433.95 1,180.75 94.74p 11.9 1.1 +11% 36.37p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Director/PDMR Shareholding 12-Jul-2024 07:00 RNS
Notice of Results 09-Jul-2024 07:00 RNS
TR1: Notification of Major Holdings 04-Jul-2024 07:00 RNS

Smith and Nephew ShareCast News

London close: Stocks rise as UK election enters ... 04-Jul-2024 ShareCast
Smith & Nephew at four-month high as activist in... 04-Jul-2024 ShareCast
London close: Stocks fall ahead of US Fed decision 01-May-2024 ShareCast

Smith and Nephew Top Newspaper Links

Smith & Nephew on the long road to recovery 17-Jul-2024 Times
Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
05-Jul-24 Buy Deepak Nath 1,643.40p 466 £7,650.75
22-May-24 Buy Dividends Deepak Nath 1,019.20p 286,648,352 £2,921,520,115.12

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,122.00p
Change Today -3.00p
% Change -0.27 %
52 Week High 1,195.50
52 Week Low 896.20
Volume 3,601,344
Shares Issued 874.35m
Market Cap £9,810m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
85.4% below the market average85.4% below the market average85.4% below the market average85.4% below the market average85.4% below the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Price Trend
6.7% below the market average6.7% below the market average6.7% below the market average6.7% below the market average6.7% below the market average
24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average24.32% above the sector average
Income
26.44% below the market average26.44% below the market average26.44% below the market average26.44% below the market average26.44% below the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
39.72% below the market average39.72% below the market average39.72% below the market average39.72% below the market average39.72% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 6
Sell 0
Strong Sell 1
Total 17
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 28-Mar-24 05-Oct-23
Paid 22-May-24 01-Nov-23
Amount 23.10¢ 14.40¢

Trades for 26-Jul-2024

Time Volume / Share Price
17:08 2,359 @ 1,124.58p
17:08 2,359 @ 1,124.80p
17:07 3,021 @ 1,124.58p
17:07 3,021 @ 1,124.80p
17:07 4,857 @ 1,124.58p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page